Richard L Morrow

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Hepatitis C Virus

Top Venues

BMJ quality & safety

BMJ evidence-based medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Richard L Morrow, Mawuena Binka, Julia Li, Mike Irvine, Sofia R Bartlett, Stanley Wong, Dahn Jeong, Jean Damascene Makuza, Jason Wong, Amanda Yu, Mel Krajden, Naveed Zafar Janjua
Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study. Viruses 16 (5) (2024)
Richard L Morrow, Mawuena Binka, Julia Li, Mike Irvine, Sofia R Bartlett, Stanley Wong, Dahn Jeong, Jean Damascene Makuza, Jason Wong, Amanda Yu, Mel Krajden, Naveed Zafar Janjua
Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study. Viruses 16 (5) (2024)
Richard L Morrow, Mawuena Binka, Julia Li, Mike Irvine, Sofia R Bartlett, Stanley Wong, Dahn Jeong, Jean Damascene Makuza, Jason Wong, Amanda Yu, Mel Krajden, Naveed Zafar Janjua
Impact of the COVID-19 Pandemic on Hepatitis C Treatment Initiation in British Columbia, Canada: An Interrupted Time Series Study. Viruses 16 (5) (2024)
Richard L Morrow, Barbara J Mintzes, Garry Gray, Michael R Law, Scott R Garrison, Colin R Dormuth
Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study. BMJ open 13 (3) (2023)
David Nunan, Kainat Bashir, Krish Bilimoria, Jasminder Birdi, Fiona Campbell, Rachel Dean, Matthew B Downer, Gabriel Gonçalves Costa, Melanie M Golob, Angille Heintzman, Mark Steven Howe, Sathya Karunananthan, Karishma Krishna Kurup, Andrea Leinberger-Jabari, Yan Luo, Nonsikelelo Mathe, Red Thaddeus D Miguel, Richard L Morrow, Caroline Scobie, Victoria South, Jenny Stavisky, Uday Narayan Yadav
Ten resources for understanding bias in health research: EBM live workshop 2022. BMJ evidence-based medicine (2023)
Richard L Morrow, Barbara J Mintzes, Garry Gray, Michael R Law, Scott R Garrison, Colin R Dormuth
Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study. BMJ open 13 (3) (2023)
Richard L Morrow, Barbara J Mintzes, Garry Gray, Michael R Law, Scott R Garrison, Colin R Dormuth
Public reporting of clinical trial findings as an ethical responsibility to participants: a qualitative study. BMJ open 13 (3) (2023)
Richard L Morrow, Barbara J Mintzes, Patrick C Souverein, Marie L De Bruin, Elizabeth Ellen Roughead, Joel Lexchin, Anna Kemp-Casey, Lorri Puil, Ingrid Sketris, Dee Mangin, Christine Erikstrup Hallgreen, Sallie-Anne Pearson, Ruth Lopert, Lisa Bero, Richard Ofori-Asenso, Danijela Gnjidic, Ameet Sarpatwari, Lucy T Perry, Colin R Dormuth
Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ quality & safety 31 (3) (2022)
Barbara J Mintzes, Ellen Reynolds, Priya Bahri, Lucy T Perry, Alice L Bhasale, Richard L Morrow, Colin R Dormuth
How do safety warnings on medicines affect prescribing? Expert opinion on drug safety 21 (10) (2022)
Richard L Morrow, Barbara Mintzes, Garry Gray, Michael R Law, Scott Garrison, Colin R Dormuth
Factors relating to nonpublication and publication bias in clinical trials in Canada: A qualitative interview study. British journal of clinical pharmacology (2022)
Richard L Morrow, Barbara Mintzes, Patrick C Souverein, Christine E Hallgreen, Bilal Ahmed, Elizabeth E Roughead, Marie L De Bruin, Sarah Brøgger Kristiansen, Joel Lexchin, Anna Kemp-Casey, Ingrid Sketris, Dee Mangin, Sallie-Anne Pearson, Lorri Puil, Ruth Lopert, Lisa Bero, Danijela Gnjidic, Ameet Sarpatwari, Colin R Dormuth
Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study. Drug safety 45 (6) (2022)